News | Cardiovascular Business | January 24, 2024

Simona Zannetti, MD, Returns to Lead Medtronic Aortic Business

Simona Zannetti, MD, General Manager of its Aortic business for Medtronic

Simona Zannetti, MD 


January 24, 2024 — Medtronic announced the recent appointment of Simona Zannetti, MD, as the General Manager of its Aortic business. Simona, who spent 21 years at Medtronic, returns after a successful stint as the SVP of clinical research at Penumbra, where she helped drive the strategic and commercial business goals of the company as a member of the senior leadership team. 

During Simona’s time at Medtronic, she played a pivotal role in establishing endovascular treatment options as a standard of care for abdominal and thoracic disease. She most recently served as VP of clinical research and medical science for the Peripheral Vascular Health Operating Unit. Simona earned her Doctor of Medicine, residency in general surgery, and fellowship in vascular surgery at the University of Perugia Medical School in Perugia, Italy. She completed a two-year research fellowship in vascular surgery at the Massachusetts General Hospital, Harvard Medical School in Boston, Massachusetts. Simona’s extensive clinical experience will contribute significantly to Medtronic and Aortic’s work to drive commercial excellence and develop life-saving treatments. 

For more information: www.medtronic.com


Related Content

News | Cardiovascular Business

July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing ...

Home July 29, 2024
Home
News | Cardiovascular Business

July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...

Home July 18, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
News | Cardiovascular Business

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
Feature | Cardiovascular Business

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
News | Cardiovascular Business

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
News | Cardiovascular Business

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
Subscribe Now